The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

MGNX FINANCIAL STATEMENTS

MacroGenics Inc — balance sheet, income statement and cash flow trends

MGNXMacroGenics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue167.7 M $Gross Profit98.4 M $ · 59%Operating Income-40.8 M $ · -24%Pre-tax Income-104.5 M $ · -62%Net Income to Owners-14.6 M $ · -9%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue167.7 M $+2.3%
Gross Profit98.4 M $+0.5%
Operating Income-40.8 M $—
EBITDA-31.1 M $—
Net Income to Owners-14.6 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets345.4 M
  • Equity42.9 M $12%
  • Current Liabilities108.8 M $32%
  • Long-term Liabilities193.7 M $56%

Key Figures

YoY change
Total Assets345.4 M $+40.7%
Total Liabilities302.5 M $+52.2%
Total Equity42.9 M $-8.0%
Cash & ST Investments173.3 M $-1.8%
Total Debt35.1 M $-67.4%
Net Debt-78.8 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-75 M-50 M-25 M0-63.7 M $Operating-13.1 M $Investing60 M $Financing-16.8 M $Net Change

Key Figures

YoY change
Operating Cash Flow-63.7 M $—
Capital Expenditures1.8 M $-25.9%
Free Cash Flow-65.5 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on MGNX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.